| 1 |
Kellum JA, Prowle JR. Paradigms of acute kidney injury in the intensive care setting[J]. Nat Rev Nephrol, 2018, 14(4): 217-230.
|
| 2 |
Husain-Syed F, Rosner MH, Ronco C. Distant organ dysfunction in acute kidney injury[J]. Acta Physiol (Oxf), 2020, 228(2): e13357.
|
| 3 |
Husain-Syed F, McCullough PA, Birk HW, et al. Cardio-Pulmonary-Renal Interactions: A Multidisciplinary Approach[J]. J Am Coll Cardiol, 2015, 65(22): 2433-2448.
|
| 4 |
Husain-Syed F, Slutsky AS, Ronco C. Lung-Kidney Cross-Talk in the Critically Ill Patient[J]. Am J Respir Crit Care Med, 2016, 194(4): 402-414.
|
| 5 |
Meersch M, Schmidt C, Hoffmeier A, et al. Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: the PrevAKI randomized controlled trial[J]. Intensive Care Med, 2017, 43(11): 1551-1561.
|
| 6 |
Gocze I, Jauch D, Gotz M, et al. Biomarker-guided Intervention to Prevent Acute Kidney Injury After Major Surgery: The Prospective Randomized BigpAK Study[J]. Ann Surg, 2018, 267(6):1013-1020.
|
| 7 |
Rewa OG, Bagshaw SM, Wang X, et al. The furosemide stress test for prediction of worsening acute kidney injury in critically ill patients: A multicenter, prospective, observational study[J]. J Crit Care, 2019, 52: 109-114.
|
| 8 |
Krzych LJ, Czempik PF. Impact of furosemide on mortality and the requirement for renal replacement therapy in acute kidney injury: a systematic review and meta-analysis of randomised trials[J]. Ann Intensive Care, 2019, 9(1): 85.
|
| 9 |
Bhatraju PK, Zelnick LR, Katz R, et al. A Prediction Model for Severe AKI in Critically Ill Adults That Incorporates Clinical and Biomarker Data[J]. Clin J Am Soc Nephrol, 2019, 14(4): 506-514.
|
| 10 |
Kim Y, Park N, Kim J, et al. Development of a new mortality scoring system for acute kidney injury with continuous renal replacement therapy. Nephrology (Carlton), 2019, 24(12): 1233-1240.
|
| 11 |
Selby NM, Casula A, Lamming L, et al. An Organizational-Level Program of Intervention for AKI: A Pragmatic Stepped Wedge Cluster Randomized Trial[J]. J Am Soc Nephrol, 2019, 30(3): 505-515.
|
| 12 |
Al-Jaghbeer M, Dealmeida D, Bilderback A, et al. Clinical Decision Support for In-Hospital AKI[J]. J Am Soc Nephrol, 2018, 29(2): 654-660.
|
| 13 |
Pasin L, Boraso S, Tiberio I. Early initiation of renal replacement therapy in critically ill patients: a meta-analysis of randomized clinical trials[J]. BMC Anesthesiol, 2019, 19(1): 62.
|
| 14 |
Yoon BR, Leem AY, Park MS, et al. Optimal timing of initiating continuous renal replacement therapy in septic shock patients with acute kidney injury[J]. Sci Rep, 2019, 9(1): 11981.
|
| 15 |
Kelly YP, Waikar SS, Mendu ML. When to stop renal replacement therapy in anticipation of renal recovery in AKI: The need for consensus guidelines[J]. Semin Dial, 2019, 32(3): 205-209.
|
| 16 |
Garzotto F, Ostermann M, Martin-Langerwerf D, et al. The Dose Response Multicentre Investigation on Fluid Assessment (DoReMIFA) in critically ill patients[J]. Crit care, 2016, 20(1): 196.
|
| 17 |
Woodward CW, Lambert J, Ortiz-Soriano V, et al. Fluid Overload Associates With Major Adverse Kidney Events in Critically Ill Patients With Acute Kidney Injury Requiring Continuous Renal Replacement Therapy[J]. Crit Care Med, 2019, 47(9): e753-e760.
|
| 18 |
Jhee JH, Lee HA, Kim S, et al. The interactive effects of input and output on managing fluid balance in patients with acute kidney injury requiring continuous renal replacement therapy[J]. Crit Care, 2019, 23(1): 329.
|
| 19 |
Zhang J, Crichton S, Dixon A, et al. Cumulative fluid accumulation is associated with the development of acute kidney injury and non-recovery of renal function: a retrospective analysis[J]. Crit Care, 2019, 23: 392.
|
| 20 |
Investigators RRTS, Bellomo R, Cass A, et al. An observational study fluid balance and patient outcomes in the Randomized Evaluation of Normal vs. Augmented Level of Replacement Therapy trial. Crit Care Med, 2012, 40(6): 1753-1760.
|
| 21 |
Atan R, Peck L, Prowle J, et al. A Double-Blind Randomized Controlled Trial of High Cutoff Versus Standard Hemofiltration in Critically Ill Patients With Acute Kidney Injury. Crit Care Med, 2018, 46(10): e988-e994.
|
| 22 |
Broman ME, Hansson F, Vincent JL, et al. Endotoxin and cytokine reducing properties of the oXiris membrane in patients with septic shock: A randomized crossover double-blind study[J]. PloS One, 2019, 14(8): e0220444.
|
| 23 |
Pickkers P, Russell JA. Treatment with a polymyxin B filter to capture endotoxin in sepsis patients: is there a signal for therapeutic efficacy?[J]. Intensive Care Med, 2019, 45(2): 282-283.
|
| 24 |
Michikoshi J, Matsumoto S, Miyawaki H, et al. Evaluation of Proteins and Cells that Adsorb to Dialysis Membranes Used in Continuous Hemodiafiltration: Comparison of AN69ST, Polymethylmethacrylate, and Polysulfone Membranes[J]. Blood Purif, 2019, 48(4): 358-367.
|
| 25 |
Lipcsey M, Tenhunen J, Sjolin J, et al. Abdominal Septic Shock-Endotoxin Adsorption Treatment (ASSET) - endotoxin removal in abdominal and urogenital septic shock with the Alteco(R) LPS Adsorber: study protocol for a double-blinded, randomized placebo-controlled trial[J]. Trials, 2016, 17: 587.
|
| 26 |
Guo Y, Ni J, Chen S, et al. MicroRNA-709 Mediates Acute Tubular Injury through Effects on Mitochondrial Function[J]. J Am Soc Nephrol, 2018, 29(2): 449-461
|
| 27 |
Poyan Mehr A, Tran MT, Ralto KM, et al. De novo NAD(+) biosynthetic impairment in acute kidney injury in humans[J]. Nat Med, 2018, 24: 1351-1359.
|
| 28 |
Katsyuba E, Mottis A, Zietak M, et al. De novo NAD(+) synthesis enhances mitochondrial function and improves health[J]. Nature, 2018, 563(7731): 354-359.
|
| 29 |
Katz NM, Kellum JA, Ronco C. Acute Kidney Stress and Prevention of Acute Kidney Injury[J]. Crit Care Med, 2019, 47: 993-996.
|